In 2025, CryoDAO, a DAO with 6,000+ members, funded 6 high-impact cryopreservation projects totaling undisclosed amounts within $65M+ industry raises; key projects include CRYORAT ($900K, initiated 25.11.2024) for high-subzero rat preservation and revival over 2025-2026, STASIS ($100K initial from CryoDAO/HydraDAO) for 8,000-9,000 sqft US facility storing 1,000-2,000 patients, plus CPA repositories, vitrified ovaries, brain preservation studies, and novel cryoprotectants.[1][2][5][6]
These developments target reversible whole-mammal cryopreservation, cryoprotectants, perfusion, and rewarming at -196°C, directly applicable to lunar habitation for medical hibernation, organ banking amid supply chain failures, and biostasis preservation reducing existential risks from radiation, isolation, or Earth catastrophes.[1][4][6]
Lunar Ark team should monitor CRYORAT revival outcomes in 2026, evaluate STASIS tokenization for DAO partnerships, research integration of cryoprotectants and ultrasound rewarming into Ark biostasis protocols, and assess CryoDAO collaboration for Moon-adapted facilities.[2][5][6]